AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2021
Jan 7, 2021
33153_dirs_2021-01-07_a85bfcf7-2d5f-4f53-9e6d-e14cab574509.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2021-01-07
Reporting Person: Sakys John (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-06 | Common Stock | M | 16 | $89.7 | Acquired | 3366 | Direct |
| 2021-01-06 | Common Stock | S | 16 | $290 | Disposed | 3350 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-06 | Non-Qualified Stock Option | $89.7 | X | 16 | Disposed | 2022-04-01 | Common Stock (16) | Direct |
Footnotes
F1: 1/7 exercisable on each anniversary date of the 4-1-2014 grant
F2: Sale reported on Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23, 2020
More from MESA LABORATORIES INC /CO/
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6
Regulatory Filings
2025
Nov 6